Literature DB >> 29108469

The Incidence of Traumatic Intracranial Hemorrhage in Head-Injured Older Adults Transported by EMS with and without Anticoagulant or Antiplatelet Use.

Daniel K Nishijima1, Samuel D Gaona1, Trent Waechter2, Ric Maloney3, Adam Blitz4, Andrew R Elms5, Roel D Farrales6, James Montoya7, Troy Bair8, Calvin Howard9, Megan Gilbert1, Renee P Trajano1, Kaela M Hatchel1, Mark Faul10, Jeneita M Bell10, Victor C Coronado10,11, David R Vinson12,13, Dustin W Ballard12,14, Daniel J Tancredi1, Hernando Garzon1, Kevin E Mackey5, Kiarash Shahlaie15, James F Holmes1.   

Abstract

Field triage guidelines recommend transport of head-injured patients on anticoagulants or antiplatelets to a higher-level trauma center based on studies suggesting a high incidence of traumatic intracranial hemorrhage (tICH). We compared the incidence of tICH in older adults transported by emergency medical services (EMS) with and without anticoagulation or antiplatelet use and evaluated the accuracies of different sets of field triage criteria to identify tICH. This was a prospective, observational study at five EMS agencies and 11 hospitals. Older adults (≥55 years) with head trauma and transported by EMS from August 2015 to September 2016 were eligible. EMS providers completed standardized data forms and patients were followed through emergency department (ED) or hospital discharge. We enrolled 1304 patients; 1147 (88%) received a cranial computed tomography (CT) scan and were eligible for analysis. Four hundred thirty-four (33%) patients had anticoagulant or antiplatelet use and 112 (10%) had tICH. The incidence of tICH in patients with (11%, 95% confidence interval [CI] 8%-14%) and without (9%, 95% CI 7%-11%) anticoagulant or antiplatelet use was similar. Anticoagulant or antiplatelet use was not predictive of tICH on adjusted analysis. Steps 1-3 criteria alone were not sensitive in identifying tICH (27%), whereas the addition of anticoagulant or antiplatelet criterion improved sensitivity (63%). Other derived sets of triage criteria were highly sensitive (>98%) but poorly specific (<11%). The incidence of tICH was similar between patients with and without anticoagulant or antiplatelet use. Use of anticoagulant or antiplatelet medications was not a risk factor for tICH. We were unable to identify a set of triage criteria that was accurate for trauma center need.

Entities:  

Keywords:  anticoagulants; field triage; head injuries; older adults

Year:  2018        PMID: 29108469      PMCID: PMC5831747          DOI: 10.1089/neu.2017.5232

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  34 in total

1.  A clinical decision rule to predict adult patients with traumatic intracranial haemorrhage who do not require intensive care unit admission.

Authors:  Daniel K Nishijima; Kiarash Shahlaie; Angela Echeverri; James F Holmes
Journal:  Injury       Date:  2011-08-11       Impact factor: 2.586

2.  Advanced statistics: missing data in clinical research--part 1: an introduction and conceptual framework.

Authors:  Jason S Haukoos; Craig D Newgard
Journal:  Acad Emerg Med       Date:  2007-05-30       Impact factor: 3.451

3.  Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection.

Authors:  Marcus D Ruopp; Neil J Perkins; Brian W Whitcomb; Enrique F Schisterman
Journal:  Biom J       Date:  2008-06       Impact factor: 2.207

4.  The impact of preinjury anticoagulants and prescription antiplatelet agents on outcomes in older patients with traumatic brain injury.

Authors:  Kimberly A Peck; Richard Y Calvo; Mark S Schechter; C Beth Sise; Jessica E Kahl; Meghan C Shackford; Steven R Shackford; Michael J Sise; Donald J Blaskiewicz
Journal:  J Trauma Acute Care Surg       Date:  2014-02       Impact factor: 3.313

5.  Out-of-hospital decision making and factors influencing the regional distribution of injured patients in a trauma system.

Authors:  Craig D Newgard; Maria J Nelson; Michael Kampp; Somnath Saha; Dana Zive; Terri Schmidt; Mohamud Daya; Jonathan Jui; Lynn Wittwer; Craig Warden; Ritu Sahni; Mark Stevens; Kyle Gorman; Karl Koenig; Dean Gubler; Pontine Rosteck; Jan Lee; Jerris R Hedges
Journal:  J Trauma       Date:  2011-06

6.  Immediate and delayed traumatic intracranial hemorrhage in patients with head trauma and preinjury warfarin or clopidogrel use.

Authors:  Daniel K Nishijima; Steven R Offerman; Dustin W Ballard; David R Vinson; Uli K Chettipally; Adina S Rauchwerger; Mary E Reed; James F Holmes
Journal:  Ann Emerg Med       Date:  2012-06       Impact factor: 5.721

Review 7.  Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review.

Authors:  Nathan Thibault; Amanda M Morrill; Kristine C Willett
Journal:  Am J Ther       Date:  2018 May/Jun       Impact factor: 2.688

8.  Elderly deaths due to ground-level falls.

Authors:  Karen M Chisholm; Richard C Harruff
Journal:  Am J Forensic Med Pathol       Date:  2010-12       Impact factor: 0.921

9.  Traumatic brain injury in an aging population.

Authors:  Nino Stocchetti; Rosalia Paternò; Giuseppe Citerio; Luigi Beretta; Angelo Colombo
Journal:  J Neurotrauma       Date:  2012-04-02       Impact factor: 5.269

10.  Intracranial complications of preinjury anticoagulation in trauma patients with head injury.

Authors:  Alfred A Mina; John F Knipfer; David Y Park; Holly A Bair; Greg A Howells; Phillip J Bendick
Journal:  J Trauma       Date:  2002-10
View more
  7 in total

1.  How Well Do EMS Providers Predict Intracranial Hemorrhage in Head-Injured Older Adults?

Authors:  Simson Hon; Samuel D Gaona; Mark Faul; James F Holmes; Daniel K Nishijima
Journal:  Prehosp Emerg Care       Date:  2019-04-23       Impact factor: 3.077

2.  The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Jacques Duranteau; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Marc Maegele; Giuseppe Nardi; Louis Riddez; Charles-Marc Samama; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2019-03-27       Impact factor: 9.097

3.  Antiplatelet therapy is associated with a high rate of intracranial hemorrhage in patients with head injuries.

Authors:  Scott M Alter; Benjamin A Mazer; Joshua J Solano; Richard D Shih; Mary J Hughes; Lisa M Clayton; Spencer W Greaves; Nhat Q Trinh; Patrick G Hughes
Journal:  Trauma Surg Acute Care Open       Date:  2020-11-25

4.  Prevalence of Intracranial Injury in Adult Patients With Blunt Head Trauma With and Without Anticoagulant or Antiplatelet Use.

Authors:  Marc A Probst; Malkeet Gupta; Gregory W Hendey; Robert M Rodriguez; Gary Winkel; George T Loo; William R Mower
Journal:  Ann Emerg Med       Date:  2020-01-17       Impact factor: 5.721

5.  Rates of Intracranial Hemorrhage in Mild Head Trauma Patients Presenting to Emergency Department and Their Management: A Comparison of Direct Oral Anticoagulant Drugs with Vitamin K Antagonists.

Authors:  Gabriele Savioli; Iride Francesca Ceresa; Sabino Luzzi; Cristian Gragnaniello; Alice Giotta Lucifero; Mattia Del Maestro; Stefano Marasco; Federica Manzoni; Luca Ciceri; Elia Gelfi; Giovanni Ricevuti; Maria Antonietta Bressan
Journal:  Medicina (Kaunas)       Date:  2020-06-23       Impact factor: 2.430

6.  National guideline for the field triage of injured patients: Recommendations of the National Expert Panel on Field Triage, 2021.

Authors:  Craig D Newgard; Peter E Fischer; Mark Gestring; Holly N Michaels; Gregory J Jurkovich; E Brooke Lerner; Mary E Fallat; Theodore R Delbridge; Joshua B Brown; Eileen M Bulger
Journal:  J Trauma Acute Care Surg       Date:  2022-04-27       Impact factor: 3.697

7.  Mechanism of injury and special considerations as predictive of serious injury: A systematic review.

Authors:  Joshua R Lupton; Cynthia Davis-O'Reilly; Rebecca M Jungbauer; Craig D Newgard; Mary E Fallat; Joshua B Brown; N Clay Mann; Gregory J Jurkovich; Eileen Bulger; Mark L Gestring; E Brooke Lerner; Roger Chou; Annette M Totten
Journal:  Acad Emerg Med       Date:  2022-04-22       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.